Israeli Firm Donates to U.S. Ten Million Pills Touted by Trump for Coronavirus Treatment by AARON KLEIN for Breitbart
More than six million tablets of hydroxychloroquine sulfate donated by the Israeli drug company Teva Pharmaceutical Industries Ltd. have arrived in the U.S. and are currently being shipped to national wholesalers to be distributed to American hospitals, a spokesperson for Teva confirmed to Breitbart News.
Ten million tablets in total are slated to arrive in the U.S. within a month as part of Teva’s donation.
The antimalaria drug has been touted by President Donald Trump as a possible treatment for Chinese coronavirus and experts say there is a theoretical basis that it could have a treatment role. Some doctors who say they have used hydroxychloroquine sulfate in conjunction with other medications have seen positive developments in Chinese coronavirus patients.
Support Our Site
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
Scientists say more trials are needed before determining the possible effectiveness of hydroxychloroquine sulfate in Chinese coronavirus treatment. Still, some doctors are already prescribing the drug on and off-label since they argue the side effects are usually not that strong and there is no time to wait for long-term data.
Hospitals are reportedly seeking to stockpile the drug in anticipation of a flood of coronavirus patients and many pharmacies say they are experiencing a massive number of prescription requests for hydroxychloroquine sulfate.
New York State began clinical trials of hydroxychloroquine on Tuesday along with zithromax and chloroquine.
Teva is one of the world’s largest makers of hydroxychloroquine. A spokesperson confirmed earlier reports that the company would ship six million tablets to wholesalers for distribution to U.S. hospitals by March 31, and more than 10 million within a month.
The spokesperson said six million tablets have already arrived in the U.S. and are being distributed to hospitals by three national wholesalers – ABC, Cardinal and McKesson.
